Showing results (271-280 of 342) with videos related to

Sort By:
Pageof 35
Melanoma Research|October 16, 2018
20-year assessment of metastatic latency and subsequent time to death after proton therapy for uveal melanomasDavid Bellocq, Pascal Roy, Laurent Kodjikian, et al.
Frontiers in Molecular Neuroscience|May 4, 2023
Peroxisomal defects in microglial cells induce a disease-associated microglial signatureQuentin Raas, Ali Tawbeh, Mounia Tahri-Joutey, et al.
Signal Transduction and Targeted Therapy|January 17, 2025
Safety and efficacy of trifluridine/tipiracil +/- bevacizumab plus XB2001 (anti-IL-1α antibody): a single-center phase 1 trialMarion Thibaudin, Nicolas Roussot, Chloé Burlot, et al.
European Journal of Epidemiology|July 13, 2021
The impact of left truncation of exposure in environmental case-control studies: evidence from breast cancer risk associated with airborne dioxinYue Zhai, Amina Amadou, Catherine Mercier, et al.
Environment International|August 13, 2024
Multi-pollutant exposure profiles associated with breast cancer risk: A Bayesian profile regression analysis in the French E3N cohortCamille Giampiccolo, Amina Amadou, Thomas Coudon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2019
Prognostic Significance of MYC Rearrangement and Translocation Partner in Diffuse Large B-Cell Lymphoma: A Study by the Lunenburg Lymphoma Biomarker ConsortiumAndreas Rosenwald, Susanne Bens, Ranjana Advani, et al.
Blood Advances|July 11, 2022
Genomic and microenvironmental landscape of stage I follicular lymphoma, compared with stage III/IVG Tjitske Los-de Vries, Wendy B C Stevens, Erik van Dijk, et al.
Cancers|June 10, 2022
Prognostic Impact of Microscopic Extra-Thyroidal Extension (mETE) on Disease Free Survival in Patients with Papillary Thyroid Carcinoma (PTC)Nadia Bouzehouane, Pascal Roy, Myriam Decaussin-Petrucci, et al.
Journal for Immunotherapy of Cancer|June 22, 2026
IL-10 secretion by CD8 T cells orchestrates early NK cell recruitment and antitumor immunity after anti-VEGFR-2/PD-1 therapyMannon Geindreau, Cassandre Pignol, Loïs Coënon, et al.
Gut Microbes|July 15, 2026
Dietary intervention through bacterial-derived butyrate elicits anti-tumor activity and increases anti-PD-1 responseMyriam Benlaïfaoui, Corentin Richard, Sébastien Hunter, et al.
Pageof 35